Nanjing Vazyme Biotech. (688105.SHG) Q3 2024 Earnings

28AugConfirmed
Q1 2023
Q2 2023
Q2 2024
Q3 2024
-0.38
-0.2
-0.01
0.17

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Nanjing Vazyme Biotech. (688105.SHG) will report earnings of for Q3 2024 on August 28, 2024.

0 Comments

Share your thoughts